JUL 11, 2018 02:56 AM PDT

Blood Pressure Medication 'Verapamil' Stimulates Insulin Production

WRITTEN BY: Nouran Amin

A common blood pressure medication, verapamil, may improve outcomes for patients with Type 1 diabetes.

According to researchers at the University of Alabama (UAB) at Birmingham Comprehensive Diabetes Center, diabetes affects more than 30 million Americans. Now, research at UAB has led to the discovery of a "safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset Type 1 diabetes."

Furthermore, verapamil, which is administered orally, will allow the patient's body to produce their very own insulin which limits the number of insulin injections needed.

"While this research is not an end-all cure for Type 1 diabetes, these findings are getting us closer to disease-altering therapies that can enable individuals with Type 1 diabetes to have more control over their disease and maintain some of their body's own insulin production," said Anath Shalev, director of UAB's CDC.

Published in Nature Medicine, the research team at UAB found a way to promote the patient's own beta cell function and insulin production.

When Shalev discovered that verapamil reversed the effects of Type 1 diabetes, human trials began.

Over a year, the clinical trials studied 24 patients between the ages of 18-45. 11 of these patients received the blood pressure medication and the other 13 received a placebo.

"Although this is a smaller sample group, our trial results give us promise that subjects with Type 1 diabetes have therapy options and that we are nearing a more effective way to deal with this disease," said Fernando Ovalle, director of UAB's Comprehensive Diabetes Clinic and co-principal investigator of the study. "Beyond verapamil allowing subjects with Type 1 diabetes the ability to live a life with less external insulin dependence, these findings will impact the quality of life that they can have."

By improving blood sugar control, patients suffering from Type 1 diabetes will experience fewer heart attacks, blindness, kidney disease and other issues.

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 15, 2018
Drug Discovery
MAY 15, 2018
Rett Syndrome: Possible Drug Treatment
A research study published in Cell Reports explains that a new drug was seen to reduce symptoms of Rett Syndrome in preclinical models while activating dor...
MAY 22, 2018
Drug Discovery
MAY 22, 2018
An Antibody Proven Effective in Treating Severe Asthma
Severe asthma is a subtype of asthma where treatments usually do not have any effect on the individual. https://www.youtube.com/watch?v=-Ih6rWNv-qY  ...
MAY 30, 2018
Drug Discovery
MAY 30, 2018
Treating Chemotherapy-Induced Pain
Recent research has studied the effects of a protein, called apolipoprotein A-I binding protein (AIBP), in mice with chemotherapy-induced pain. It is a new...
JUL 17, 2018
Drug Discovery
JUL 17, 2018
Hunger Hormones for Addiction Treatment?
Hunger hormones, or gut hormones, work to signal the body's state of hunger and fullness. These hormones could potentially serve as a key new treatment...
SEP 08, 2018
Drug Discovery
SEP 08, 2018
Protein Associated With ALS Inspires Drug Treatments
Neurodegenerative diseases, such as degenerative ataxia or amyotrophic lateral sclerosis (ALS), will progressively cause an affected individual to develop ...
SEP 11, 2018
Drug Discovery
SEP 11, 2018
Stimuli-Responsive Nanoparticles as a Drug Delivery Method
Researchers at Washington State University (WSU), who were finding a way to fight an inflammatory response that causes organ failure better known as sepsis...
Loading Comments...